Washington Oregon Biotech Networks | Seattle, Portland and regional news, jobs, and events

  • Home
  • About
  • News
    • All News
    • Trending News & Jobs
  • Jobs
    • All Jobs
    • Featured Jobs
    • Post a Job
  • Subscribe
  • Contact
News Ticker
  • [ September 29, 2023 ] Health research funding to Oregon slowed in 2022 News
  • [ September 29, 2023 ] Legacy doctors and nurse practitioners file for union recognition News
  • [ September 29, 2023 ] Exclusive: Former Genentech duo reunites to push Sonoma into the clinic; Ex-Magenta commercial chief heads to Editas News
  • [ September 29, 2023 ] Sonoma Biotherapeutics Appoints Joseph R. Arron, M.D., Ph.D., as Chief Scientific Officer and Mark D. Eisner, M.D., MPH, as Chief Medical Officer News
  • [ September 29, 2023 ] Associate Director, Bioassays – Absci – Vancouver, WA Jobs
HomeNewsSeagen shareholders approve $43B acquisition by Pfizer

Seagen shareholders approve $43B acquisition by Pfizer

June 2, 2023 WOBN News, Syndication Comments Off on Seagen shareholders approve $43B acquisition by Pfizer

The companies still face at least one more hurdle before they can finalize the deal.
Click here to view original post

Previous

Opinion: What you need to know about Washington’s long-term care payroll tax

Next

Affini-T Therapeutics Appoints Industry Veteran Thaminda Ramanayake, M.S., MBA, as Chief Business Officer

Follow/Subscribe

WOBN Jobs

POST A JOB

WOBN Featured Jobs

  • Field Application Scientist, SF Bay & Oregon | NanoString | Remote SF Bay/Oregon
    August 29, 2023 0

Tweets by WOBionetwork


Advertise With Biotech Networks

Copyright © 2023 Biotech Networks, LLC

Get Biotech Networks Briefs in Your Inbox: Trending News & Featured Jobs